Literature DB >> 21458243

Implementation of an optimized strategy for genetic testing of the Chinese patients with oculocutaneous albinism.

Aihua Wei1, Xiumin Yang, Shi Lian, Wei Li.   

Abstract

BACKGROUND: Oculocutaneous albinism (OCA) is a relatively common inherited disorder in all populations worldwide. The mutational spectra of OCA are population-specific.
OBJECTIVE: Based on our previous molecular epidemiological studies, we have implemented an optimized strategy for the genetic testing of Chinese OCA patients.
METHODS: Genomic DNA was extracted from the blood samples of 52 clinically diagnosed OCA patients and 100 unaffected subjects. The amplified DNA segments were screened for mutations of TYR, OCA2, TYRP1, SLC45A2 and HPS1 by direct sequencing. To exclude the previously unidentified alleles (PUAs) from polymorphisms, samples from 100 unaffected controls were sequenced for the same regions of variations.
RESULTS: Among the 52 OCA patients, 26 (50.0%) were found mutations on TYR gene, 8 (15.4%) on OCA2, 12 (23.1%) on SLC45A2, 2 (3.8%) on HPS1, and 4 (7.7%) patients uncharacterized. We identified 18 PUAs in these patients, 2 in TYR, 7 in OCA2, 8 in SLC45A2, and 1 in HPS1.
CONCLUSION: The optimized method to screen the OCA mutations is efficiently implemented in the routine genetic testing of Chinese OCA patients accompanied with genetic counseling.
Copyright © 2011 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458243     DOI: 10.1016/j.jdermsci.2011.02.009

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  6 in total

1.  The BLOS1-interacting protein KXD1 is involved in the biogenesis of lysosome-related organelles.

Authors:  Qing Yang; Xin He; Lin Yang; Zhiyong Zhou; Andrew R Cullinane; Aihua Wei; Zhe Zhang; Zhenhua Hao; Aili Zhang; Min He; Yaqin Feng; Xiang Gao; William A Gahl; Marjan Huizing; Wei Li
Journal:  Traffic       Date:  2012-05-28       Impact factor: 6.215

2.  Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.

Authors:  Qi Yang; Sheng Yi; Mengting Li; Bobo Xie; Jinsi Luo; Jin Wang; Xiuliang Rong; Qinle Zhang; Zailong Qin; Limei Hang; Shihan Feng; Xin Fan
Journal:  BMC Med Genet       Date:  2019-06-13       Impact factor: 2.103

3.  Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism.

Authors:  Linya Ma; Jianjian Zhu; Jing Wang; Yazhou Huang; Jibo Zhang; Chao Wang; Yuan Zhou; Dan Peng
Journal:  Front Genet       Date:  2021-10-11       Impact factor: 4.599

4.  Hermansky-Pudlak syndrome: Mutation update.

Authors:  Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico
Journal:  Hum Mutat       Date:  2020-01-23       Impact factor: 4.700

5.  Mutational analysis of a Chinese family with oculocutaneous albinism type 2.

Authors:  Xiong Wang; Yaowu Zhu; Na Shen; Jing Peng; Chunyu Wang; Haiyi Liu; Yanjun Lu
Journal:  Oncotarget       Date:  2017-07-31

6.  Burden of albinism: development and validation of a burden assessment tool.

Authors:  Fanny Morice-Picard; Charles Taïeb; Aurelie Marti; Antoine Gliksohn; Mohammed Bennani; Christine Bodemer; Khaled Ezzedine
Journal:  Orphanet J Rare Dis       Date:  2018-09-18       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.